View More Recent Stories
-
Bernstein SocGen Group Starts Biohaven Pharmaceutical Holding (BHVN) at Outperform
-
Biohaven Pharma (BHVN) Misses Q2 EPS by 172c
-
RBC's biotech survey shows investors more bearish vs. last time
-
Morgan Stanley Starts Biohaven Pharmaceutical Holding (BHVN) at Overweight
-
2Q24 U.S. biotech earnings preview
-
Benitec Biopharma (BNTC) Announces Appointment of Kishen Mehta to its Board of Directors
-
TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
-
RBC Capital Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)


